Related Experiment Video
Updated: Jun 18, 2026

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
Insulin signaling regulates mitochondrial function in pancreatic beta-cells
Siming Liu1, Terumasa Okada, Anke Assmann
1Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.
Insulin signaling is crucial for pancreatic beta-cell mitochondrial function. Disrupting insulin receptors impairs a key protein complex, affecting metabolism and contributing to type 2 diabetes.
Area of Science:
- Cell Biology
- Metabolic Disease Research
- Endocrinology
Background:
- Insulin and IGF-I signaling pathways are vital for regulating metabolism in mammalian tissues, particularly pancreatic islets.
- Mitochondrial dysfunction is a hallmark of beta-cell failure in type 2 diabetes.
- Understanding the link between insulin signaling and mitochondrial function is critical for addressing diabetes pathogenesis.
Purpose of the Study:
- To elucidate the mechanisms connecting insulin signaling to mitochondrial function within pancreatic beta-cells.
- To identify key components of the insulin-signaling pathway that interact with mitochondria.
- To investigate the role of these interactions in the context of type 2 diabetes.
Main Methods:
- Identification of a mitochondria-tethering complex in beta-cells containing glucokinase (GK) and BAD(S).
- Analysis of mitochondrial function and complex composition in beta-cell specific insulin receptor knockout (betaIRKO) mice.
- Comparison of betaIRKO mouse islets with islets from patients with type 2 diabetes.
- Assessment of protein expression, phosphorylation, and complex stoichiometry following insulin receptor re-expression.
Main Results:
- BetaIRKO mice exhibited reduced BAD(S), GK, and protein kinase A within the mitochondrial complex, alongside impaired mitochondrial function.
- Similar molecular and functional alterations were observed in islets from type 2 diabetes patients.
- Decreased mitochondrial GK activity in betaIRKOs was linked to reduced BAD(S) expression and altered phosphorylation.
- Elevated p70S6K and JNK1 phosphorylation suggested a compensatory increase in IGF-1 receptor signaling.
- Re-expression of insulin receptors partially restored complex stoichiometry and mitochondrial function.
Conclusions:
- Insulin signaling directly regulates mitochondrial function in pancreatic beta-cells through a specific protein complex.
- Dysregulation of this complex, involving BAD(S) and GK, contributes to beta-cell dysfunction observed in type 2 diabetes.
- Targeting the insulin signaling pathway and its mitochondrial interactions may offer therapeutic strategies for type 2 diabetes.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Insulin Secretory Vesicles
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Type II Diabetes II: Pathophysiology
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...

